Barclays PLC Dare Bioscience, Inc. Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.21 - $1.89 $424 - $663	-351 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.31 - $3.0 $459 - $1,053	351 New	351 $1,000
Q1 2019 May 15, 2019	SELL	$0.73 - $2.1 $10,220 - $29,400	-14,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.63 - $1.12 $5,293 - $9,410	8,402 Added 150.09%	14,000 $10,000
Q3 2018 Nov 14, 2018	SELL	$0.92 - $1.43 $2,208 - $3,432	-2,400 Reduced 30.01%	5,598 $5,000
Q2 2018 Aug 14, 2018	SELL	$0.76 - $1.48 $6,078 - $11,837	-7,998 Reduced 50.0%	7,998 $9,000
Q1 2018 May 15, 2018	BUY	$0.83 - $2.79 $13,276 - $44,628	15,996 New	15,996 $13,000

7.23M

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $277M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.